Clinical Trial Update: A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Enlicitide (MK-0616-037) in hyperlipidemia; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• Enlicitide

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hyperlipidemia | Phase 3 | Status: RECRUITING